Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab.
Dervite
I
I
Hober
D
D
Morel
P
P
D000208:Acute Disease; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006509:Hepatitis B / Q000209:etiology*; D006510:Hepatitis B Antibodies / Q000097:blood*; D006514:Hepatitis B Surface Antigens / Q000097:blood / Q000276:immunology*; D006801:Humans; D008224:Lymphoma, Follicular / Q000150:complications / Q000188:drug therapy; D008297:Male; D012008:Recurrence; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D000069283:Rituximab